Bromday Versus Nevanac Eye Drops to Control Pain Following Photorefractive Keratectomy

• Status: Completed
• Trial end date: 2012-05-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will compare the effect of two topical non-steroidal antiinflammatory agents to control pain after photorefractive keratectomy (PRK) eye surgery.

• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Virdi Eye Clinic
• Treatments: Bromfenac; Nepafenac

Criteria

Inclusion Criteria:

• male or female at least 18 years of age,

• no other ocular studies with 15 days prior to dosing,

• BCVA 20/200 or better,

• return for study visits and follow instructions from investigator and staff,

• self administer test article

Exclusion Criteria:

• Ocular inflammation,

• hypersensitivity to bromfenac or nepafenac,

• any corneal pathology,

• have had radial keratotomy,

• corneal transplant or corneal refractive surgery in the last two years